Physician profile
Mark R Hedrick
NPI 1689614505
$3,975.96
in general payments reported to CMS, 2019-2025
28 companies · $639 in 2025
The $639 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,110 · 2020: $172 · 2021: $16.04 · 2022: $669 · 2023: $161 · 2024: $210 · 2025: $639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,010.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,009.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,131.23 | 2022-2025 | Citrefix, Inbone, Prostep |
| Wright Medical Technology, INC. | $1,012.10 | 2019-2020 | |
| Smith+Nephew, INC. | $912.81 | 2019-2022 | |
| Abbott Laboratories | $137.62 | 2020-2022 | |
| Treace Medical Concepts, INC. | $106.24 | 2022-2025 | |
| Medshape, INC. | $64.35 | 2019 | |
| Depuy Synthes Sales INC. | $63.75 | 2025 | Lcp |
| Orthofix Medical, INC. | $58.91 | 2019-2025 | Physio-Stim |
| Paragon 28, INC. | $51.56 | 2019 | |
| Endo Pharmaceuticals INC. | $42.30 | 2019-2020 | |
| Bioventus LLC | $40.86 | 2019 | |
| Pacira Therapeutics, INC. | $36.62 | 2019 | |
| Ethicon US, LLC | $36.34 | 2022-2025 | Ethicon, Vistaseal |
| Vericel Corporation | $24.20 | 2023 | Maci |
| Sanofi-Aventis U.S. LLC | $23.75 | 2023 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ermi LLC | $22.51 | 2019 | |
| Nevro Corp. | $21.74 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $21.34 | 2024 | Exparel, Zilretta, Iovera |
| Vertex Pharmaceuticals Incorporated | $19.89 | 2025 | |
| Fidia Pharma USA INC. | $19.66 | 2023 | Hymovis |
| Mallinckrodt Enterprises LLC | $19.24 | 2019 | |
| Breg, INC | $18.63 | 2022 | |
| Peerless Surgical INC. | $16.22 | 2019 | |
| Zimmer Biomet Holdings, INC. | $16.08 | 2019 | |
| Kci USA, INC. | $16.04 | 2021 | |
| Davol INC. | $14.49 | 2025 | |
| Sanara Medtech INC. | $14.30 | 2020 | |
| Nuvasive, INC. | $13.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hedrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.